Industry Spotlight  |
Neuroscience Discovery

Interview with Nicolas Vachicouras, CEO, Neurosoft Bioelectronics: Subdural Brain Interfaces

Edited by Tom Cohen |
01 November 2023
Talking with Nicolas Vachicouras, CEO of Neurosoft Bioelectronics about their subdural brain interface and its inaugural clinical testing for recording the human brain in the context of an epilepsy resective surgery.

Like this interview? See related articles and videos:

Join and network with over 450 industry discovery biology and chemistry leaders at the renowned Drug Discovery Summit in Basel, where they address critical strategies in target identification, validation
and HIT optimisation of small and large molecule drugs

Together with Neuroscience Drug Development Europe, attendees especially benefit from a 2-day event addressing emerging strategies for the drug development of neuroscience and successful approaches
for more targeted, precise, and transformative therapies to neurodegenerative and neuropsychiatric diseases.

How would you rate this content?

Share this article

Sign up for our monthly Discovery Newsletter

You may also be interested in...

Insight Article
Identifying disease targets, understanding complex biology, and developing effective technologies for target engagement.
18 August 2023
Industry Spotlight
Positive phase III results propel innovative pherine nasal spray as potential game-changer for millions struggling with social anxiety disorder. Vistagen's novel mechanism of action sparks optimism after previous setback.
08 August 2023

Continue browsing

Share this article

Join our Discovery mailing list

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Discovery